Subscribe now

WHILE a cure for multiple sclerosis remains elusive, silencing key messengers
of the immune system might halt and even reverse its debilitating symptoms.
Several groups are now developing drugs to do this after promising tests in
animals.

MS is a result of immune cells attacking the protective myelin sheath that
coats nerves in the brain and spinal cord, causing a variety of symptoms such as
numbness, weakness and paralysis. What triggers this autoimmune reaction still
isn’t known.

But studies have shown that the cerebrospinal fluid in MS sufferers often
contains abnormally high levels of certain chemical signals called chemokines.
These…

Sign up to our weekly newsletter

Receive a weekly dose of discovery in your inbox. We'll also keep you up to date with New Scientist events and special offers.

Sign up

To continue reading, subscribe today with our introductory offers

Popular articles

Trending New Scientist articles

Piano Exit Overlay Banner Mobile Piano Exit Overlay Banner Desktop